Danaher Corp
Change company Symbol lookup
Select an option...
DHR Danaher Corp
CSCO Cisco Systems Inc
BIP Brookfield Infrastructure Partners LP
OGS ONE Gas Inc
GM General Motors Co
VCYT Veracyte Inc
BLUE bluebird bio Inc
GWPAX American Funds Growth Portfolio Class A
LIXTW Lixte Biotechnology Holdings Equity Warrants Exp 1st Jan 2025 *W EXP 01/01/2025
ZIONP Zions Bancorporation NA
Go

Health Care : Health Care Equipment & Supplies | Large Cap Growth
Company profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Closing Price
$251.80
Day's Change
2.49 (1.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
254.50
Day's Low
246.35
Volume
(Average)
Volume:
2,426,624

10-day average volume:
2,682,046
2,426,624

Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial, and commercial products and services. The Company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of instruments and consumables that are primarily used by customers to study the basic building blocks of life, including genes, proteins, metabolites, and cells, to understand the causes of disease, identify new therapies, and test and manufacture new drugs and vaccines. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services that hospitals, physicians’ offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solutions segment offers products and services that help protect precious resources and keep global food and water supplies safe.

Valuation Ratios

Price/Earnings (TTM)
29.26x
Price/Sales (TTM)
5.99x
Price/Book (MRQ)
4.14x
Price/Cash Flow (TTM)
21.48x
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend

Short Interest

April 2022
Current Month
4.4M
Previous Month
4.9M
Percent of Float
0.68%
Days to Cover
1.3023 Days

Share Information

DHR is in a share class of common stock
Float
647.2M
Shares Outstanding
727.1M
Institutions Holding Shares
2,671
77.32%

Financial Statements

Balance sheet

Values displayed are in millions.

Income statement

Values displayed are in millions.

Cash flow

Values displayed are in millions.

Company Officers

  • Steven M. RalesChmn.
  • Rainer M. BlairPres.
  • Mitchell P. Rales
  • Matthew R. McGrewCFO
  • Jennifer L. HoneycuttExec.VP

Address

  • 2200 Pennsylvania Ave Nw Ste 800W
  • Washington, DC 20037-1731
  • Phone: (202) 828-0850
  • Fax: (202) 828-0860
  • https://www.danaher.com/

Insider Trading

During the most recent quarter, 200 shares were bought, and 100K shares were sold in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.